Area of research
Immunology · Oncology
Research interest
Research focused on T cell and Myeloid leukemia, with related work in Immunotherapy, Downregulation and upregulation, Flow cytometry. Notable publications include 'BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia', 'TOX as a potential target for immunotherapy in lymphocytic malignancies', and 'Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia'.
Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes
BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
Increased TOX expression associates with exhausted T cells in patients with multiple myeloma
TOX as a potential target for immunotherapy in lymphocytic malignancies
Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia
Characteristics of <i>TCRζ</i> , <i>ZAP-70</i> , and <i>FcɛRIγ</i> Gene Expression in Patients with T- and NK/T-Cell Lymphoma